TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19672115

Group type: EXPERIMENTAL
Intervention: Dead Sea mineral-enriched body lotion (DS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo lotion with no Dead Sea minerals (P1)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo lotion with no active ingredients (P2)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Combined placebo groups (P1 and P2)
Number of subjects: 78
Study: 17218057

Group type: EXPERIMENTAL
Intervention: Multimodal physiotherapy program (MPT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Self-management program (SMP)
Number of subjects: 71
Study: 16377592

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12109234

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ventilator hyperinflation
Number of subjects: 20
Study: 9855261

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not treated with H. pylori eradication)
Number of subjects: 45
Study: 7530168

Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy
Number of subjects: 392

Group type: COMPARATOR
Intervention: m‐BACOD chemotherapy
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: LDH level normal or below
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: LDH level 1-3 x normal
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: LDH level > 3 x normal
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: International Index low risk group
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: International Index low/intermediate risk group
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: International Index high/intermediate risk group
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: International Index high risk group
Number of subjects: 392
Study: 2225700

Group type: EXPERIMENTAL
Intervention: 1500 mg mefloquine hydrochloride
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 750 mg mefloquine hydrochloride
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 750 mg and 1500 mg mefloquine hydrochloride
Number of subjects: 37
Study: 634895

Group type: EXPERIMENTAL
Intervention: TNS (transcutaneous nerve stimulation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pethidine (50 mg intravenously)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unspecific TNS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 31670238

Group type: EXPERIMENTAL
Intervention: Combination of all four image contrasts (FLAIR, T1, T2, proton density)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: FLAIR alone
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: All image combinations
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Lesion size
Number of subjects: 1000
Study: 31719124

Group type: EXPERIMENTAL
Intervention: Standard of care plus sequencing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 28111430

Group type: EXPERIMENTAL
Intervention: CCRT with erlotinib followed by erlotinib (arm A)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: CCRT with irinotecan-cisplatin (IP) only (arm B)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: IP before CCRT (arm C)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: IP after CCRT (arm D)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EGFR-mutant patients
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EGFR-wild patients
Number of subjects: 59
Study: 25204231

Group type: EXPERIMENTAL
Intervention: Hands-on exercise (group 1)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cognitive exercise (group 2)
Number of subjects: 94

Group type: COMPARATOR
Intervention: No warm-up (control, group 3)
Number of subjects: 94
Study: 22935738

Group type: EXPERIMENTAL
Intervention: Lowered BMI category or remained in healthy or overweight groups
Number of subjects: 3998

Group type: COMPARATOR
Intervention: Stayed obese
Number of subjects: 3998

Group type: EXPERIMENTAL
Intervention: Decreased a BMI category
Number of subjects: 3998

Group type: EXPERIMENTAL
Intervention: Increased a BMI category
Number of subjects: 3998
Study: 21270194

Group type: EXPERIMENTAL
Intervention: Fasting Plasma Glucose (FPG) ≥ 126 mg/dL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HbA(1c) ≥ 6.5%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both FPG and HbA(1c)
Number of subjects: 0
Study: 18377903

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 74
Study: 16197921

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion (0.1 mmol/kg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 14510997

Group type: EXPERIMENTAL
Intervention: TAC in Transfersome (2.5 micro g cm‐2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAC cream (25 micro g cm‐2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAC ointment (25 micro g cm‐2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAC in Transfersome
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAC cream
Number of subjects: 0
Study: 10761963

Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurses (nurses A, B, and C) for low-risk participants.
Number of subjects: 791

Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurses (nurses A and B) for low-risk participants.
Number of subjects: 791

Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurse C for low-risk participants.
Number of subjects: 791

Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits for high-risk participants.
Number of subjects: 791
Study: 8798244

Group type: EXPERIMENTAL
Intervention: Special premature formula (PF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fortified human milk (HM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study: 1450797

Group type: EXPERIMENTAL
Intervention: Diclofenac 50 mg and Misoprostol 200 micrograms
Number of subjects: 361

Group type: COMPARATOR
Intervention: Diclofenac 50 mg and Placebo
Number of subjects: 361
Study: 6372261

Group type: EXPERIMENTAL
Intervention: Forced Diffusion Ventilation (FDV)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High Frequency Pulsation (HFP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intermittent Positive Pressure Ventilation (IPPV)
Number of subjects: 23
Study: 31383583

Group type: EXPERIMENTAL
Intervention: More intensive reminders
Number of subjects: 20757

Group type: EXPERIMENTAL
Intervention: Shorter inter-donation intervals
Number of subjects: 20757

Group type: COMPARATOR
Intervention: Routine reminders
Number of subjects: 20757
Study: 29223708

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham transcranial magnetic stimulation/sham tDCS
Number of subjects: 41
Study: 26541138

Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 25691677

Group type: EXPERIMENTAL
Intervention: Androgen-Deprivation Therapy plus Radiotherapy (ADT+RT)
Number of subjects: 1205

Group type: COMPARATOR
Intervention: Androgen-Deprivation Therapy alone (ADT)
Number of subjects: 1205
Study: 22905934

Group type: EXPERIMENTAL
Intervention: True narratives (trip to a theme park)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: False narratives (hot air balloon ride)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonbelieved memories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with nonbelieved memories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with false memories who retracted their claim
Number of subjects: 0
Study: 21199265

Group type: EXPERIMENTAL
Intervention: colesevelam 3.75 g/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 19112781

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 619
Study: 17132352

Group type: EXPERIMENTAL
Intervention: General practice-based complex intervention to support the implementation of clinical guidelines for hepatitis C management
Number of subjects: 26

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: General practice-based complex intervention
Number of subjects: 26
Study: 12973958

Group type: EXPERIMENTAL
Intervention: adrenaline 0.5 microgram/kg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: adrenaline 0.5 microgram/kg and clonidine 0.3 microgram/kg
Number of subjects: 75

Group type: COMPARATOR
Intervention: clonidine 0.3 microgram/kg
Number of subjects: 75
Study: 10798541

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PBSCT
Number of subjects: 28
Study: 9403260

Group type: EXPERIMENTAL
Intervention: Once daily application of povidone-iodine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Twice daily application of povidone-iodine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Once or twice daily application of povidone-iodine
Number of subjects: 72
Study: 7917797

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily
Number of subjects: 296

Group type: COMPARATOR
Intervention: Amoxycillin 250 mg three times daily
Number of subjects: 296
Study: 2844087

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study: 30515164

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF) + GOS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF) + GOS + vitamin D
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 15
Study: 28349708

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 25738794

Group type: EXPERIMENTAL
Intervention: Early surgery (hematoma evacuation within 12h of randomization)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Initial conservative treatment (subsequent evacuation allowed if deemed necessary)
Number of subjects: 170
Study: 24765719

Group type: EXPERIMENTAL
Intervention: Self‐Concept Enhancement Program (SCEP) for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 60
Study: 22659382

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 0
Study: 20204945

Group type: EXPERIMENTAL
Intervention: Enhanced counselling (EC) intervention
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control condition (standard individualised counselling + general health information session)
Number of subjects: 134
Study: 18541328

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 15818104

Group type: COMPARATOR
Intervention: Increased PLA2 levels in BAL fluid, BAL cells, and plasma in ARDS patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Type IIA secretory and cytosolic PLA2 in BAL fluid
Number of subjects: 31

Group type: COMPARATOR
Intervention: Total PLA2 activity
Number of subjects: 31

Group type: COMPARATOR
Intervention: Higher PLA2 activity in direct ARDS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Higher platelet-activating-factor acetylhydrolase activity in BAL fluid and plasma
Number of subjects: 31
Study: 12271281

Group type: EXPERIMENTAL
Intervention: Cryotherapy followed by topical imiquimod and salicylic acid
Number of subjects: 3
Study: 10357032

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 340

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 340
Study: 9364674

Group type: EXPERIMENTAL
Intervention: S‐L* vaccine (20 micrograms/dose)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Engerix‐B vaccine (20 micrograms/dose)
Number of subjects: 100
Study: 1494594

Group type: EXPERIMENTAL
Intervention: Haloperidol and lorazepam combined
Number of subjects: 61

Group type: COMPARATOR
Intervention: Haloperidol alone
Number of subjects: 61
Study: 3083705

Group type: EXPERIMENTAL
Intervention: Oral neomycin and erythromycin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous metronidazole and ceftriaxone
Number of subjects: 60
Study: 30956983

Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 328

Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Solifenacin and Mirabegron
Number of subjects: 328
Study: 29912663

Group type: EXPERIMENTAL
Intervention: Stem cell therapy (bone marrow-derived mononuclear cells)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Compression therapy alone (control group)
Number of subjects: 40
Study: 27113487

Group type: EXPERIMENTAL
Intervention: Interim pressure garment (IPG) therapy (4-6 mmHg) applied post-operatively on day 5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no compression to donor sites)
Number of subjects: 0
Study: 24831251

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus 10 mg zolpidem nightly
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) alone
Number of subjects: 160
Study: 21910714

Group type: EXPERIMENTAL
Intervention: 311-nm UVB therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (unirradiated body halves)
Number of subjects: 10
Study: 20216207

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC) plus Dopamine (DA) infusion
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC) infusion
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 43
Study: 18541389

Group type: EXPERIMENTAL
Intervention: Modafinil (200mg/day)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 157
Study: 16082540

Group type: EXPERIMENTAL
Intervention: Computer-assisted image-free navigation system (study group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Free-hand implantation (control group)
Number of subjects: 45
Study: 11837736

Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interferon-alpha and cisapride
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interferon-beta
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Interferon-beta and cisapride
Number of subjects: 48
Study: 10037308

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minilaparotomy
Number of subjects: 0
Study: 7722910

Group type: EXPERIMENTAL
Intervention: 0.03% flurbiprofen
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: 1% indomethacin
Number of subjects: 681

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 681
Study: 8314480

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 MU three times weekly for three months
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 MU three times weekly for six months
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 6 MU two times weekly for six months
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 6 MU three times weekly for six months
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 4
Study: 3886256

Group type: EXPERIMENTAL
Intervention: 1 gm imipenem and cilastatin every 6 hours for 10 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29964249

Group type: EXPERIMENTAL
Intervention: Dual-curing resin cement (Calibra)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Light-curing flowable composite (Charisma Flow)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Calibra and Charisma Flow
Number of subjects: 36

Group type: COMPARATOR
Intervention: Charisma Flow and RelyX Unicem
Number of subjects: 36

Group type: COMPARATOR
Intervention: Calibra and RelyX Unicem
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flowable composite (Charisma Flow)
Number of subjects: 36
Study: 27721533

Group type: EXPERIMENTAL
Intervention: Chloroquine 10 mg/kg on Day 1, 10 mg/kg on Day 2, and 5 mg/kg on Day 3
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (normally nourished children)
Number of subjects: 25
Study: 24990776

Group type: EXPERIMENTAL
Intervention: Vipromak added to treatment protocol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment scheme
Number of subjects: 80
Study: 22677218

Group type: EXPERIMENTAL
Intervention: milnacipran 100 mg/d
Number of subjects: 516

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 516
Study: 20482594

Group type: EXPERIMENTAL
Intervention: Pioglitazone (group DP) for 12 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sulfonylurea (group DS) for 12 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Comparison between group DP and group DS
Number of subjects: 98
Study: 17986678

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 27945299

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy: docetaxel 75 mg/m² and cisplatin 75 mg/m² D1 q 3 wks x 2, followed by cisplatin 40 mg/m² weekly x 6-8 concurrent with RT (66 Gy in 2-Gy fractions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control arm: concurrent cisplatin-RT as arm 1 without neoadjuvant chemotherapy
Number of subjects: 60
Study: 11986439

Group type: EXPERIMENTAL
Intervention: Apple juice (sorbitol 0.5 g/dL; 2.6:1 fructose-to-glucose ratio)
Number of subjects: 30

Group type: COMPARATOR
Intervention: White grape juice (sorbitol-free; 1:1 fructose-to-glucose ratio)
Number of subjects: 30
Study: 10717776

Group type: EXPERIMENTAL
Intervention: LNG/EE (Levonorgestrel 100 micrograms + Ethinyl Estradiol 20 micrograms)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: NETA/EE (Norethindrone Acetate 1000 micrograms + Ethinyl Estradiol 20 micrograms)
Number of subjects: 58
Study: 7741611

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Concentric training
Number of subjects: 20
Study: 2199890

Group type: EXPERIMENTAL
Intervention: Single running suture with postoperative suture adjustment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard double running suture procedure with no postoperative adjustment
Number of subjects: 18
Study: 7267475

Group type: EXPERIMENTAL
Intervention: prenylamine 180 mg daily
Number of subjects: 29
Study: 31837201

Group type: EXPERIMENTAL
Intervention: Self-management retraining program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study: 29951803

Group type: EXPERIMENTAL
Intervention: Polymer-free BA9-coated stent (DCS)
Number of subjects: 805

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 805
Study: 28129756

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and cognitive behavioural therapy based intervention for AUDs, administered over 16 sessions at 8 HIV clinics.
Number of subjects: 0

Group type: COMPARATOR
Intervention: World Health Organization Mental Health Gap Action Programme (WHO mhGAP) guide, adapted for the Zimbabwean context.
Number of subjects: 0
Study: 25886009

Group type: EXPERIMENTAL
Intervention: mHealth intervention (MINSTOP app)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 23843062

Group type: EXPERIMENTAL
Intervention: Oxybutynin treatment (Group I)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (Group II)
Number of subjects: 47
Study: 21279328

Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 20002420

Group type: EXPERIMENTAL
Intervention: Major trauma group
Number of subjects: 565

Group type: COMPARATOR
Intervention: Minor or no trauma group
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Women with minor or no trauma
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Women with major trauma
Number of subjects: 565
Study: 17970680

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing (SRP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Full-Mouth Scaling (FMS)
Number of subjects: 37
Study: 15555005

Group type: EXPERIMENTAL
Intervention: Fleet Prep Kit 3 (FPK #3) - single dose (45 ml) oral sodium phosphate (NaP), four bisacodyl tablets (5 mg), and one bisacodyl enema (10 mg)
Number of subjects: 171

Group type: COMPARATOR
Intervention: 4 L polyethylene glycol solution (PEG)
Number of subjects: 171
Study: 11869753

Group type: EXPERIMENTAL
Intervention: Integrated, clinic-based treatment delivery system emphasizing algorithm-driven somatotherapy, standardized patient education, and easy access to a primary mental health care provider.
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual VA care
Number of subjects: 191
Study: 9590631

Group type: EXPERIMENTAL
Intervention: Cod liver oil (CLO)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Seal oil/CLO
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Whale oil (refined or unrefined)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: CLO/olive oil
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: CLO/seal oil
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Olive oil/CLO
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 266